1,362 reports of this reaction
3.1% of all ORLISTAT reports
#9 most reported adverse reaction
ABDOMINAL PAIN UPPER is the #9 most commonly reported adverse reaction for ORLISTAT, manufactured by Haleon US Holdings LLC. There are 1,362 FDA adverse event reports linking ORLISTAT to ABDOMINAL PAIN UPPER. This represents approximately 3.1% of all 43,367 adverse event reports for this drug.
Patients taking ORLISTAT who experience abdominal pain upper should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ABDOMINAL PAIN UPPER is moderately reported among ORLISTAT users, representing a notable but not dominant share of adverse events.
In addition to abdominal pain upper, the following adverse reactions have been reported for ORLISTAT:
The following drugs have also been linked to abdominal pain upper in FDA adverse event reports:
ABDOMINAL PAIN UPPER has been reported as an adverse event in 1,362 FDA reports for ORLISTAT. This does not prove causation, but indicates an association observed in post-market surveillance data.
ABDOMINAL PAIN UPPER accounts for approximately 3.1% of all adverse event reports for ORLISTAT, making it a notable side effect.
If you experience abdominal pain upper while taking ORLISTAT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.